Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer
Clinical trial NCT00892567 · COMPLETED
Trial details
- NCT number
- NCT00892567
- Sponsor
- Craig L Slingluff, Jr
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.